Target intelligence / Profile preview

Keratin 18 pseudogene 16 (KRT18P16)

Target: KRT18P16
Molecular classification: Other, Pseudogene

Overview

Keratin 18 pseudogene 16 (KRT18P16) is a processed pseudogene derived from the KRT18 gene, which encodes an intermediate filament protein critical for epithelial cell structure and has significance in several cancers. However, KRT18P16 itself does not encode a functional protein, has no known cellular or disease-related role, and is not considered a therapeutic target, biomarker, or drug interaction partner. As with other processed pseudogenes, it is a remnant of evolutionary gene duplication/retrotransposition and lacks an intact open reading frame and biological function[3][5].

Other names: KRT18P16

Beyond the preview

Go deeper on Keratin 18 pseudogene 16 (KRT18P16).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Keratin 18 pseudogene 16 (KRT18P16).

Explore the full profile